ACADIA Pharmaceuticals Inc.
MX ˙ BMV ˙ US0042251084
SecurityMX:ACAD / ACADIA Pharmaceuticals Inc.
InstitutionLPL Financial LLC
Latest Disclosed Ownership36,617 shares
Latest Disclosed Value $ 815,083
LPL Financial LLC reports 8.80% decrease in ownership of ACAD / ACADIA Pharmaceuticals Inc.

On May 6, 2026 - LPL Financial LLC filed a 13F-HR form disclosing ownership of 36,617 shares of ACADIA Pharmaceuticals Inc. (MX:ACAD) valued at $815,083 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 40,152 shares of ACADIA Pharmaceuticals Inc.. This represents a change in shares of -8.80% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 36,617 -3,535 -8.80 815 -23.97 0.0002
2026-02-11 2025-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 40,152 4,258 11.86 1,072 40.13 0.0003
2025-11-12 2025-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 35,894 -5,559 -13.41 766 -14.43 0.0002
2025-08-12 2025-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 41,453 13,206 46.75 894 90.62 0.0003
2025-05-07 2025-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 28,247 1,877 7.12 469 -2.90 0.0002
2025-02-11 2024-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 26,370 -47,043 -64.08 484 -57.22 0.0002
2024-11-08 2024-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 73,413 1,006 1.39 1,129 -4.00 0.0005
2024-08-07 2024-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 72,407 12,515 20.90 1,177 6.23 0.0006
2024-05-10 2024-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 59,892 -3,178 -5.04 1,107 -43.92 0.0006
2024-02-14 2023-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 63,070 4,828 8.29 1,975 62.74 0.0012
2023-11-13 2023-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 58,242 5,850 11.17 1,214 -3.27 0.0008
2023-07-31 2023-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 52,392 5,708 12.23 1,255 42.82 0.0009
2023-05-10 2023-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 46,684 9,127 24.30 879 47.07 0.0007
2023-02-07 2022-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 37,557 -158 -0.42 598 -3.24 0.0005
2022-11-14 2022-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 37,715 -940 -2.43 617 13.21 0.0006
2022-08-12 2022-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 38,655 -688 -1.75 545 -42.81 0.0005
2022-05-16 2022-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 39,343 1,352 3.56 953 7.44 0.0008
2022-02-14 2021-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 37,991 -13,677 -26.47 887 3.38 0.0007
2021-11-15 2021-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 51,668 4,610 9.80 858 -25.26 0.0008
2021-08-13 2021-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 47,058 7,093 17.75 1,148 11.35 0.0012
2021-05-14 2021-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 39,965 -1,436 -3.47 1,031 -53.41 0.0012
2021-02-12 2020-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 41,401 4,167 11.19 2,213 44.08 0.0029
2020-11-09 2020-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 37,234 418 1.14 1,536 -13.90 0.0024
2020-08-13 2020-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 36,816 713 1.97 1,784 16.98 0.0031
2020-05-14 2020-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 36,103 -20,464 -36.18 1,525 -36.98 0.0033
2020-02-14 2019-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 56,567 3,331 6.26 2,420 26.30 0.0044
2019-11-13 2019-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 53,236 -70,344 -56.92 1,916 -41.99 0.0039
2019-08-09 2019-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 123,580 4,585 3.85 3,303 3.38 0.0070
2019-05-08 2019-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 118,995 -2,110 -1.74 3,195 63.18 0.0073
2019-02-07 2018-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 121,105 -9,663 -7.39 1,958 -27.88 0.0052
2018-11-14 2018-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 130,768 -9,986 -7.09 2,715 26.34 0.0065
2018-08-14 2018-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 140,754 -9,150 -6.10 2,149 -36.19 0.0056
2018-05-15 2018-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 149,904 -8,768 -5.53 3,368 -29.51 0.0093
2018-02-14 2017-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 158,672 65,517 70.33 4,778 36.16 0.0145
2017-11-14 2017-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 93,155 1,200 1.30 3,509 36.80 0.0124
2017-08-14 2017-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 91,955 91,955 2,565 0.0097
2017-05-15 2017-03-31 13F ACADIA PHARMACEUTICAL COM 004225108 0 -23,705 -100.00 0 -100.00
2017-02-13 2016-12-31 13F ACADIA PHARMACEUTICAL COM 004225108 23,705 23,705 0.00 682 0.0052
2016-08-15 2016-06-30 13F ACADIA PHARMACEUTICAL COM 004225108 0 -20,346 -100.00 0 -100.00
2016-05-16 2016-03-31 13F ACADIA PHARMACEUTICAL COM 004225108 20,346 6,350 45.37 608 26.14 0.0017
2016-02-12 2015-12-31 13F ACADIA PHARMACEUTICAL COM 004225108 13,996 7,339 110.24 482 110.48 0.0013
2015-11-13 2015-09-30 13F ACADIA PHARMACEUTICAL COM 004225108 6,657 6,657 229 0.0013
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.